RULING: SPCs are not available for new uses of already authorised medicines
The CJEU has reached a decision in Santen C-673/18, relating to whether an SPC may be granted for a new use of an already authorised medicinal product […]
The CJEU has reached a decision in Santen C-673/18, relating to whether an SPC may be granted for a new use of an already authorised medicinal product […]
Decisions about patentability of plants and animals have gone back and forth over the last couple of years. Read more […]
Owners of IP now need to reassess their IP strategy and make sure it still fits into a world that has been turned upside down […]
Only nine percent of SMEs recognize the importance of protecting their IPR. But IPR should be part of the business strategy from day one. Learn why […]
Yesterday, at the Managing IP annual awards, Plougmann Vingtoft accepted their second “Firm of the year” award in 2020. Read more […]
Last night, Plougmann Vingtoft were in London to attend the Global IP Awards and bring home the highly regarded “Firm of the year” trophy. Read more […]
We are fast approaching the deadline for Brexit, on 31 January 2020. Click here to stay up to date on the latest Brexit news […]
Innovation is booming, but way too many start-ups neglect the importance of IP rights. We have asked IP-experts and investors about the consequences […]
Four of our trademark experts will be influential in INTA committees in 2020/2021. Click to learn more about their focus areas […]
On 1 January 2020, Plougmann Vingtoft welcomes Hegner & Partners A/S to the firm. They hereby expand their list of IP-consultants and range of services. Read more […]